IP Library Granted Patent US 7,244,574
Granted Patent B2
US 7,244,574 · App. 10/472,283 · Granted Jul 17, 2007

Method of assaying lupus anticoagulant and assay reagent

Assignee: Eisai Co., Ltd
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,244,574
App. No.
10/472,283
Granted
Jul 17, 2007
Kind
B2
Abstract

A monoclonal antibody having inhibitory activity on blood coagulation reactions, which reacts with prothrombin forming a complex with phosphatidylserine but does not react with prothrombin not forming a complex with phosphatidylserine; and a method for measuring inhibitory activity of test plasma on blood coagulation reactions, which comprises the steps of (1) measuring inhibitory activity of the test plasma on the blood coagulation reactions and inhibitory activity of this on the blood coagulation reactions, and (2) comparing the inhibitory activity of the test plasma with the inhibitory activity of this antibody.

Claims (12)

1. An antibody produced by 231D cells (FERM BP-7936).

2. A method for comparing an inhibitory activity of plasma from a lupus patient with the inhibitory activity of a standard antibody on a blood coagulation reaction, comprising the steps of:

(1) measuring the inhibitory activity of the plasma on the blood coagulation reaction;

(2) measuring the inhibitory activity of the antibody as defined in claim 1 on the blood coagulation reaction, and

(3) comparing the inhibitory activity of the plasma with the inhibitory activity of the antibody.

3. A method for determining a lupus anticoagulant level in plasma from a lupus patient, comprising the steps of:

(1) measuring the inhibitory activity of the lupus patient's plasma on a blood coagulation reaction;

(2) measuring the inhibitory activity of the antibody as defined in claim 1 on the blood coagulation reaction, and

(3) comparing the inhibitory activity of the lupus patient's plasma with the inhibitory activity of the antibody to express the inhibitory activity of the lupus patient's plasma as a level of the antibody; and

(4) determining a lupus anticoagulant level by using the level of the antibody as an index.

4. The method according to claim 2 , wherein the method for measuring the inhibitory activity on blood coagulation reactions is selected from the group consisting of measurement of prolongation of activated partial thromboplastin time, measurement of prolongation of kaolin clotting time, and measurement of prolongation of dilute Russell's viper venom time, or a combination thereof.

5. A reagent for measuring lupus anticoagulant, which comprises the monoclonal antibody as defined in claim 1 and a carrier.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2007
From: EISAI CO., LTD.
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 019235/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2003
From: ATSUMI, TATSUYA; KOIKE, TAKAO
To: EISAI CO., LTD.
Reel/Frame 014931/0024 →
Priority Claims (1)
JP 2001-077366 · Mar 19, 2001 · national
Continuity (1)
Related Publication 20040110242A1 · Jun 10, 2004